GlassScriptPhysician profile
Brandee Black
NPI 1477864429
$4,576.13
in general payments reported to CMS, 2019-2025
19 companies · $408 in 2025
The $408 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,702 · 2020: $21.68 · 2021: $30.90 · 2022: $1,699 · 2023: $349 · 2024: $365 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,122.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,356.65 | 2019 | |
| Anika Therapeutics, INC. | $1,298.29 | 2022 | |
| Orthofix Medical, INC. | $284.75 | 2023-2025 | Physio-Stim, Accelstim |
| Stryker Corporation | $253.04 | 2019-2024 | Mako, Inspace, Iconix |
| Trimed, INC. | $212.82 | 2022-2024 | |
| Zimmer Biomet Holdings, INC. | $186.54 | 2023 | Comprehensive |
| Biocomposites INC | $170.94 | 2025 | Stimulan |
| Endo Pharmaceuticals INC. | $131.33 | 2019-2022 | |
| Kci USA, INC. | $125.00 | 2022 | |
| Medtronic USA, INC. | $122.34 | 2019-2020 | |
| Bioventus LLC | $122.06 | 2019-2023 | Durolane |
| Abbott Laboratories | $87.91 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $74.98 | 2022 | |
| Dynasplint Systems INC. | $31.65 | 2025 | Dynasplint |
| Biom'Up France Sas | $30.90 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $25.74 | 2019 | |
| Elevate Surgical Co | $24.69 | 2025 | |
| Heron Therapeutics, INC. | $21.69 | 2022 | |
| Avanos Medical | $14.81 | 2024 | Genvisc 850 Sodium Hyaluronate |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandee Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.